All eyes will be on Brazil in August for a favorite international pastime: the Summer Olympics. But since a bombshell report came out last November chronicling a major athlete doping scandal in Russia, some have wondered how clean the competition in Rio de Janeiro will be. The report, released by the World Anti-Doping Agency (WADA), the global organization that promulgates a code of standards governing athletes’ use of performance-enhancing substances and oversees the code’s enforcement by national and regional drug testing authorities, prompted a ban of the Russian track and field team from the games. In late June, problems got worse when WADA suspended the local lab in Rio responsible for testing athletes at the games because of the lab’s nonconformity with international testing standards.
Dionne Koller, professor at the University of Baltimore School of Law and director of its Center for Sport and the Law, spoke to Rebekah Mintzer about the challenges that the international community is facing in regulating the use of performance-enhancing drugs.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]